Results 31 to 40 of about 2,408,243 (341)

Study protocol: The Adherence and Intensification of Medications (AIM) study - a cluster randomized controlled effectiveness study [PDF]

, 2010
Background Many patients with diabetes have poor blood pressure (BP) control. Pharmacological therapy is the cornerstone of effective BP treatment, yet there are high rates both of poor medication adherence and failure to intensify medications ...
Bosworth, Hayden B, Heisler, Michele M., Hofer, Timothy P., Hogan, Mary M., Kerr, Eve A., Klamerus, Mandi L., Schmittdiel, Julie, Selby, Joe V., Tremblay, Adam   +8 more
core   +5 more sources

A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric patients with extracranial solid tumors (ST) receiving chemotherapy are at an increased risk for Pneumocystis jirovecii pneumonia (PJP). However, evidence guiding prophylaxis practices in this population is limited. A PJP‐related fatality at our institution highlighted inconsistent prescribing approaches and concerns about
Kriti Kumar, Denise M. Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Furqan Shaikh, Paul C. Nathan, Meredith S. Irwin, Sarah Cohen‐Gogo   +8 more
wiley   +1 more source

Reducing Medication Errors Through Workflow Redesign [PDF]

, 2017
Lack of medication reconciliation at the point of transitions between skilled nursing facilities/nursing homes (SNF/NHs) and acute care hospitals (ACHs) is a common point of origin for medical errors that cause harm to patients.
Blake, Rosslyn W, DNP, APRN, GNP
core   +1 more source

Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Sickle cell disease (SCD) and asthma share a complex relationship. Although estimates vary, asthma prevalence in children with SCD is believed to be comparable to or higher than the general population. Determining whether SCD confers an increased risk for asthma remains challenging due to overlapping symptoms and the ...
Suhei C. Zuleta De Bernardis, Okeleji Olayinka, Mariam Z. Quraishi, Lakshmi V. Srivaths, Deborah L. Brown, Neethu M. Menon, Ricardo A. Mosquera, Ashwin P. Patel, James M. Stark, Aravind Yadav   +9 more
wiley   +1 more source

Medical nemesis [PDF]

Journal of Epidemiology and Community Health, 1974
This article was originally published in the Lancet in 1974.† It is reprinted here, as the centre of a set of articles, in memory of the death of Ivan Illich in December 2002.
openaire   +2 more sources

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background While Wilms tumor (WT) typically has a favorable prognosis, relapsed cases—especially those with high‐risk histology—remain therapeutically challenging after intensive frontline therapy. The combination of vincristine and irinotecan has demonstrated activity in pediatric solid tumors, and pazopanib, a multi‐targeted tyrosine kinase ...
Maria Debora De Pasquale, Alessandro Crocoli, Giuseppe Maria Milano, Pierluigi Di Paolo, Francesca Diomedi Camassei, Ida Russo, Annalisa Serra   +6 more
wiley   +1 more source

Design of MARQUIS2: study protocol for a mentored implementation study of an evidence-based toolkit to improve patient safety through medication reconciliation. [PDF]

, 2019
BackgroundThe first Multi-center Medication Reconciliation Quality Improvement Study (MARQUIS1) demonstrated that implementation of a medication reconciliation best practices toolkit decreased total unintentional medication discrepancies in five ...
Chu, Eugene, Dalal, Anuj, Goldstein, Jenna, Gresham, Marcus, Howell, Eric, Kripalani, Sunil, Labonville, Stephanie, Levin, Brian, Mallouk, Meghan, MARQUIS2 Site Leaders, MARQUIS2 Study Group, Mixon, Amanda S, Mueller, Stephanie, Nieva, Harry Reyes, Nyenpan, Christopher, Orav, John, Platt, Sara, Rennke, Stephanie, Schnipper, Jeffrey L, Smith, G Randy, Sridharan, Anirudh, Stein, Jason M, Stolldorf, Deonni, Wetterneck, Tosha, Williams, Mark, Yoon, Catherine   +25 more
core  

Supporting adherence to oral anticancer agents : clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists [PDF]

, 2017
Background: Healthcare provider (HCP) activities and attitudes towards patients strongly influence medication adherence. The aim of this study was to assess current clinical practices to support patients in adhering to treatment with oral anticancer ...
Boons, Christel CLM, Hugtenburg, Jacqueline G, Timmers, Lonneke, van den Bemt, Bart JF, Van Hecke, Ann, Verbrugghe, Mathieu   +5 more
core   +3 more sources

Potential Early Risk Biomarkers for Reduced Forced Expiratory Volume in Children Post‐Hematopoietic Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT We sought to identify potential early risk biomarkers for lung disease in children post‐allogeneic HCT. Patients with pulmonary function tests 3 months post‐transplant and plasma samples between days 7 and 14 post‐HCT were included. Six of 27 subjects enrolled had reduced forced expiratory volume 1 (FEV1) z scores.
Isabella S. Small, Pi Chun Cheng, April L. Rahrig, Courtney M. Rowan   +3 more
wiley   +1 more source

Brand and generic use of inhalation medication and frequency of switching in children and adults : a population-based cohort study [PDF]

, 2018
BACKGROUND: The expiration of patents of brand inhalation medications and the ongoing pressure on healthcare budgets resulted in a growing market for generics.
de Jongste, Johan C, Engelkes, Marjolein, Herings, Ron CM, Janssens, Hettie M, Kuiper, Josephine, Overbeek, Jetty A, Sturkenboom, Miriam CJM, van Blijderveen, Jan C, Verhamme, Katia   +8 more
core   +1 more source